Article Information
History
- March 27, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Iraseni Swai1,2,*,
- Lisa Lynn ten Bergen3,4,
- Alan Mtenga1,6,
- Rehema Maro1,6,
- Kennedy Ngowi1,2,
- Benson Mtesha1,
- Naomi Lekashingo1,
- Takondwa Msosa2,5,
- Tobias F. Rinke de Wit3,7,
- Rob Aarnoutse8 and
- Marion Sumari-de Boer1,3,9,10
- 1Kilimanjaro Clinical Research Institute, Moshi, Tanzania
- 2UMC Amsterdam, Location AMC, Amsterdam, the Netherlands
- 3Amsterdam UMC, location University of Amsterdam, Department of Global Health, Amsterdam Institute for Global Health and Development, Amsterdam, the Netherlands
- 4Vrije Universiteit Amsterdam, the Netherlands
- 5Helse Nord Tuberculosis Initiative, Kamuzu University of Health Sciences, Blantyre, Malawi
- 6Ifakara Health Institute, Bagamoyo, Tanzania
- 7PharmAccess Foundation, Amsterdam, the Netherlands
- 8Radboud university medical center, Department of Pharmacy, Research Institute for Medical Innovation, Nijmegen, the Netherlands
- 9Institute of Public Health, Kilimanjaro Christian Medical University College, Moshi, Tanzania
- 10Knowledge, Innovation and Technology Group, Wageningen University & Research, the Netherlands
- ↵*Corresponding author: Iraseni Ufoo Swai, MD, Kilimanjaro Clinical Research Institute (KCRI), P.O. Box 2236, Moshi, Tanzania Email: i.swai{at}kcri.ac.tz